SIMPLEX TRADING, LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$51
-22.7%
25,391
-12.1%
0.00%
Q2 2023$66
+371.4%
28,893
+486.1%
0.00%
Q1 2023$14
-86.9%
4,930
-89.3%
0.00%
Q4 2022$107
-99.9%
46,010
+13.4%
0.00%
Q3 2022$77,000
-78.0%
40,556
-68.7%
0.00%
Q2 2022$350,000
-9.3%
129,391
-0.3%
0.00%
Q1 2022$386,000
-50.8%
129,814
-35.7%
0.00%
-100.0%
Q4 2021$785,000
+735.1%
201,963
+572.2%
0.00%
Q3 2021$94,000
+4.4%
30,043
+0.8%
0.00%
Q2 2021$90,00029,794
+86.7%
0.00%
Q1 2021$0
-100.0%
15,955
-86.4%
0.00%
-100.0%
Q4 2020$416,000
+246.7%
117,235
+170.5%
0.00%
Q4 2019$120,00043,344
+10244.6%
0.00%
Q3 2019$0
-100.0%
419
-37.6%
0.00%
Q2 2019$1,000
-98.6%
671
-91.3%
0.00%
Q3 2018$72,000
+4.3%
7,700
-19.4%
0.00%
Q2 2018$69,000
+97.1%
9,551
+35.8%
0.00%
-100.0%
Q1 2018$35,000
+150.0%
7,031
+151.7%
0.00%
+100.0%
Q4 2017$14,000
+133.3%
2,793
+45.9%
0.00%
Q2 2017$6,000
+200.0%
1,914
+110.6%
0.00%
Q1 2017$2,000
-98.5%
909
-98.3%
0.00%
-100.0%
Q4 2016$133,000
+84.7%
54,527
+158.0%
0.01%
+60.0%
Q3 2016$72,000
+200.0%
21,138
+197.3%
0.01%
+150.0%
Q2 2016$24,0000.0%7,110
+21.3%
0.00%0.0%
Q1 2016$24,000
+118.2%
5,861
+122.4%
0.00%
+100.0%
Q4 2015$11,000
-65.6%
2,635
-50.2%
0.00%
-50.0%
Q3 2015$32,0005,2930.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q4 2020
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 340,000$1,459,0000.53%
RTW INVESTMENTS, LP 4,733,323$20,306,0000.31%
APIS CAPITAL ADVISORS, LLC 70,000$300,0000.29%
Hudson Bay Capital Management LP 1,800,000$7,722,0000.10%
COWEN AND COMPANY, LLC 249,215$1,069,0000.05%
Kerrisdale Advisers, LLC 100,000$429,0000.05%
Woodline Partners LP 496,172$2,129,0000.04%
Shay Capital LLC 60,000$257,0000.03%
Walleye Capital LLC 231,037$991,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 212,700$912,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders